The objective of this study is to investigate if VR as a pre-module improves the willingness to start with exposure in vivo.
ID
Source
Brief title
Condition
- Anxiety disorders and symptoms
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
- willingness to take part in exposure in vivo
Measured with the Friedman-test (non-parametric).
When they differ significantly we will use post-hoc analyses (Wilcoxon Signed
Rank Test with a Bonferroni correction).
Secondary outcome
Anxiety Expectancy, activation of anxiety, approachability and course of
symptoms (anxiety/depression) will be visual reproduced as descriptive
statistics.
Background summary
CBT in adolescents and adults with a panic disorder or social phobia needs
improvement.
Patients drop-out during the treatment or it's difficult to motivate for
exposure in vivo to anxiety induced environments.
Virtual reality seems to be an promising intervention. A lot of studies studied
the effects of VR as a treatment for anxiety disorders.
The objective of this study is to investigate if VR as a pre-module improves
the willingness to start with exposure in vivo.
Study objective
The objective of this study is to investigate if VR as a pre-module improves
the willingness to start with exposure in vivo.
Study design
The study design which will be used for this study is a single casedesign with
repeated measures.
Intervention
Four VR sessions in which participants will be exposed to public traffic, a
supermarket, a shopping district and a party in the garden.
Study burden and risks
The risk of participation in this study can be cybersickness.
Participants will be informed about this and it's always a possibility to stop
their participation in this study.
Tarweweg 2
Nijmegen 6534AM
NL
Tarweweg 2
Nijmegen 6534AM
NL
Listed location countries
Age
Inclusion criteria
- DSM-5 diagnosis: panic disorder or social phobia, measured with the MINI KID
(adolescents) or MINI (adults)
- Age between 12 and 18 (adolescents) of 18+
Exclusion criteria
- patients are diagnosed with a severe depressive disorder for which they need
immediate treatment (measured with the MINI or MINI KID)
- patients are diagnosed with a psychosis for which they need immediate
treatment (measured with the MINI or MINI KID)
- Mental retardation (IQ below 70)
- Substance abuse or dependence or alcohol abuse or dependence
- Psychofarmacology is changed in the last 8 weeks
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL72392.091.19 |